Work

From manufacturing to patient: Ensuring stability and integrity of frozen faecal microbiota capsules during storage and shipping in the setting of the FRESCO trial

Year: 2025

Type: conference-paper

Abstract: Background: The ongoing FRESCO trial [ref:1] is designed to assess the efficacy and safety of long-term (12 weeks) oral administration of frozen encapsulated faecal microbiota (FM) and a sterile microbiota filtrate (FMF) compared to placebo (PL) in patients with mild to moderate active ulcerative [for full text, please go to the a.m. URL]

Source: German Medical Science (German Research Foundation)

DOI: 10.3205/25gaa22

Authors: Thürmer, Maria, Linhardt, Claudia, Junca, Howard, Steube, Arndt, Merkel, Ute, Pieper, Dietmar H., Kiehntopf, Michael, Stallmach, Andreas, Hartmann, Michael

Institutions: Jena University Hospital, Helmholtz Centre for Infection Research

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W7105222579

FWCI:

Cites:

Cited by:

Related to: